Bioelectronics Corp (BIEL)

[Simpsonly]

Content of that post is twisted speculation requiring clarity of thought. . . .

"Company-likely-knows-FDA-status-ask-yourself-why-not-disclosing-publicly"

Company does know status of FDA 510(k) submission OTC clearance process - it is still under review, otherwise there would have been a press release, at the company's discretion to all Officers, Directors and shareholders on the shareholders e-mail listing and the public simultaneously. This forum would obviously be sometime later, when information is posted about it after those four groups.


"The fact the FDA Clearance status is not known publicly is 99% probability because not good news considering the PR Speculation and subsequent TOXIC Dilution strategy in play with this company."

Statement mingles and confuses FDA Clearance, still under review, wild speculation, and dilution resulting from imaginative and well known and understood financing model.


"If there was even the slightest bit of good news concerning FDA there would be PR's and company facilitated dumping via TOXIC Dilution"

Again, statement confusingly mingles expected FDA 510(k) OTC Clearance and well-known financing model. One could assume a PR when FDA OTC Clearance, which has nothing to do with anything else. Hope this helps with clarity of thought - less confusing.